Dose escalation for prostate cancer which dose for which person?

Frontiers of Radiation Therapy and Oncology

Volumn 36, Issue , 2002, Pages 10-15

  Sandler, Howard M ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Department of Radiation Oncology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; CLINICAL TRIAL; COHORT ANALYSIS; CONSENSUS DEVELOPMENT; HUMAN; MALE; PATIENT SELECTION; PRACTICE GUIDELINE; PROSTATE TUMOR; RADIATION DOSE; RADIATION INJURY; RADIATION RESPONSE; RADIOTHERAPY; RETROSPECTIVE STUDY; REVIEW; TREATMENT OUTCOME;

ADENOCARCINOMA; CLINICAL TRIALS; COHORT STUDIES; CONSENSUS DEVELOPMENT CONFERENCES; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; PATIENT SELECTION; PRACTICE GUIDELINES; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0036366253     PISSN: 00719676     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000061322     Document Type: Article

References (14)

1. Hanks GE, Hanlon AL, Pinover WH, Horwitz EM, Price RA, Schultheiss T: Dose selection for prostate cancer patients based on dose comparison and dose-response studies. Int Radiat Oncol Biol Phys 2000;46:823-832.
2. Lyons JA, Kupelian PA, Mohan DS, Reddy CA, Klein EA: Importance of high radiation doses (72 y or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate. Urology 2000;55: 85-90.
3. Zelefsky MJ, Leibel SA, Gaudin PB, Kutcher GJ, Fleshner NE, Venkatramen ES, Reuter VE, Fair WR, Ling CC, Fuks Z: Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Radiat Oncol Biol Phys 1998;41:491-500.
4. Valicenti R, Lu J, Pilepich M, Asbell S, Grignon D: Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials. J Clin Oncol 2000;18:2740-2746.
5. Consensus Statement: Guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys 1997;37:1035-1041.
6. Vicini FA, Kestin LL, Martinez AA: The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys 1999;45: 553-561.
7. Pollack A, Zagars GK, Smith LG, Lee JJ, von Eschenbach AC, Antolak JA, Starkschall G, Rosen I: Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 y for prostate cancer. J Clin Oncol 2000;18:3904-3911.
8. Hanks GE, Hanlon AL, Pinover WH, Horwitz EM, Schultheiss TE: Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy. Cancer J Sci Am 1999;5:152-158.
9. Shipley WU, Verhey LJ, Munzenrider JE, Suit HD, Urie MM, McManus PL, Young RH, Shipley JW, Zietman AL, Biggs PJ et al: Advanced prostate cancer: The results of a randomized comparative trial of high-dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 1995;32:3-12.
10. Shipley WU, Tepper JE, Prout G Jr, Verhey LJ, Mendiondo OA, Goitein M, Koehler AM, Suit HD: Proton radiation as boost therapy for localized prostatic carcinoma. JAMA 1979;241:1912-1915.
11. Roach M 3rd, Marquez C, Yuo HS, Narayan P, Coleman L, Nseyo UO, Navvab Z, Carroll PR: Predicting the risk of lymph node involvement using the pre-treatment prostate-specific antigen and Gleason score in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1994;28:33-37.
12. Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG: Development and validation of the expanded prostate cancer index composite for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000;56:899-905.
13. Sandler HM, Dunn RL, Wei JT, McLaughlin PW, Henning GT, Sanda MG: Health-related quality of life following 3D conformal external beam radiotherapy: Treatment factors influence patientreported outcome. Int J radiat Oncol Biol Phys 2000;48:249.
14. Fukunaga-Jonson N, Sandler HM, McLaughlin PW, Strawderman MS, Grijalva KH, Kish KE, Lichter AS: Results of 3D conformal radiotherapy in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 1997;38:311-317.